| 2021-11-01 | Sale | Merck & Co., Inc. MRK | EVP, Chief Patient Officer | 96,270 0.0038% | $87.91 | $8.46M | +0.83% | |
| 2020-07-17 | Sale | Merck & Co., Inc. MRK | EVP Strat Comm, GI Pub Policy | 72,570 0.0026% | $73.69 | $5.35M | +1.35% | |
| 2020-01-13 | Sale | Merck & Co., Inc. MRK | EVP Strat Comm, GI Pub Policy | 204,146 0.0081% | $89.34 | $18.24M | -8.14% | |
| 2018-11-07 | Sale | Merck & Co., Inc. MRK | EVP Strat Comm, Gl Pub Policy | 72,436 0.0024% | $64.91 | $4.7M | +9.61% | |
| 2018-05-15 | Sale | Merck & Co., Inc. MRK | EVP Strat Comm, Gl Pub Policy | 19,944 0.0008% | $59.66 | $1.19M | +26.16% | |
| 2016-11-07 | Sale | Merck & Co., Inc. MRK | EVP Strat Comm, Gl Pub Policy | 171,046 0.0062% | $60.02 | $10.27M | +7.38% | |
| 2015-05-08 | Sale | Merck & Co., Inc. MRK | EVP Strat Comm, Gl Pub Policy | 76,736 0.0027% | $60.99 | $4.68M | -9.72% |